Abstract:Background Despite much improvement in the treatment for acute lymphoblastic leukemia (ALL), childhood ALLs with MLL -rearrangement ( MLL -r) still have inferior dismal prognosis. Thus, defining mechanisms underlying MLL -r ALL maintenance is critical for developing effective therapy. Methods GSE13159 and GSE28497 were selected via the Oncomine website. Differentially expressed genes (DEGs) between MLL -r ALLs and normal samples were identified by R software. Next, functional enrichment analysis of these DEGs were carried out by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Then, the key hub genes and modules were identified by Weighted Gene Co-expression Network Analysis (WGCNA). Therapeutically Applicable Research to Generate Effective Treatments (TARGET) ALL (Phase I) of UCSC Xena analysis, qPCR, and Kaplan-Meier analysis were conducted for validating the expression of key hub genes from bone marrow cells of childhood ALL patients or ALL cell lines. Results A total of 1,045 DEGs were identified from GSE13159 and GSE28497. Through GO, KEGG, GSEA, and STRING analysis, we demonstrated that MLL -r ALLs were upregulating “nucleosome assembly” and “B cell receptor signal pathway” genes or proteins. WGCNA analysis found 18 gene modules using hierarchical clustering between MLL -r ALLs and normal. The Venn diagram was used to filter the 98 hub genes found in the key module with the 1,045 DEGs. We identified 18 hub genes from this process, 9 of which were found to be correlated with MLL -r status, using the UCSC Xena analysis. By using qPCR, we validated these 9 hub key genes to be upregulated in the MLL -r ALLs (RS4;11 and SEM) compared to the non- MLL -r ALL (RCH-ACV) cell lines. Three of these genes, BCL11A , GLT8D1 and NCBP2, were shown to be increased in MLL -r ALL patient bone marrows compared to the non- MLL -r ALL patient. Finally, Kaplan–Meier analysis indicated that childhood ALL patients with high BCL11A expression had significantly poor overall survival. Conclusion These findings suggest that upregulated BCL11A gene expression in childhood ALLs may lead to MLL -r ALL development and BCL11A represents a new potential therapeutic target for childhood MLL -r ALL.

Molecular Analysis Of T-Lineage Commitment: A Possible Role For Bcl11b

Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation

Single-cell Transcriptomic Reconstruction Reveals Cell Cycle and Multi-Lineage Differentiation Defects in Bcl11a -Deficient Hematopoietic Stem Cells

Critical roles of Bcl11b in T‐cell development and maintenance of T‐cell identity

Detailed Analysis of Gene Expression During Development of T Cell Lineages in the Thymus.

Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b

A Bcl6 Intronic Element Regulates T Follicular Helper Cell Differentiation

The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.

Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.

The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment

Bcl6 is the nexus transcription factor of T follicular helper cell (TFH) differentiation via a set of repressor-of-repressor gene circuits

Identification of Gene Regulatory Networks in B-Cell Progenitor Differentiation and Leukemia

BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases

Additional File 2: Table S2. of Single-cell Transcriptomic Reconstruction Reveals Cell Cycle and Multi-Lineage Differentiation Defects in Bcl11a-deficient Hematopoietic Stem Cells

Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms

Bcl11b, A Novel Gata3-Interacting Protein, Regulates T-Helper-2-Cell Differentiation and Function

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

A critical role for TCF-1 in T-lineage specification and differentiation

Transcriptional Regulatory Logic Orchestrating Lymphoid and Myeloid Cell Fate Decisions

Transcriptional Repressor BCL11A in Erythroid Cells